Tag:
HIV
Latest Headlines
Latest Headlines
Mothers' breast milk may carry HIV fighting tool
Duke University scientists have uncovered another tool that they think will help defeat the HIV virus: antibodies in breast milk.
Cipla partnership plans $50 million expansion in Uganda
A partnership between Quality Chemical Industries and Cipla is preparing to expand a manufacturing operation in Luzira, Uganda, where it makes HIV drugs.
New study confirms worst fears about Merck's HIV vaccine
Five years ago Merck investigators stunned everyone working in the AIDS research field with the news that they were abruptly halting a study of a prospective HIV vaccine after the data began to make clear that it wasn't only failing to guard against the virus, but appeared to increase the risk of becoming infected.
OraSure's OTC HIV test obtains crucial FDA panel backing
There isn't an approved over-the-counter home HIV diagnostic test yet. But OraSure stepped even closer to that milestone on Tuesday, when the FDA's Blood Products Advisory Committee voted unanimously to recommend approving the company's product.
FDA panel OKs Gilead's key HIV drug Quad
The four-in-one pill for HIV won support from an FDA advisory committee Friday, bolstering the Foster City, CA-based company's efforts to gain approval of the drug and maintain its top position in the market for HIV and AIDS drugs.
FDA advisory panel backs Truvada for HIV prevention
It is two down and one to go for Truvada, the Gilead Sciences ($GLD) HIV medication. An FDA advisory panel, following the lead of the agency staff, recommended 19-3 that the drug be prescribed to people at high risk as a preventive against HIV infection.
Support seen for U.S. plan to speed nods for 'breakthrough' drugs
This year the agency and U.S. lawmakers appear to be supportive of a plan that would help pharma groups race to the market with breakthrough drugs.
Truvada up for FDA debate as HIV preventive
Should an HIV treatment become a prophylactic? That's the question an FDA panel will address later this week.
NIH, U.S. agencies pay for nearly half of global health R&D
Uncle Sam has been a champion of backing research of global health concerns that plague populations well outside of U.S. borders, according to a study by Global Health Technologies.
Stem cell/gene therapy holds HIV at bay in mouse trials
Scientists have successfully transplanted anti-HIV stem cells into mice that served as surrogates for infected patients. Bigger still, however, the process successfully expanded and safeguarded HIV-resistant immune cells, and the cells themselves kept growing even when confronted with the virus.
